Inhoudsopgave
Advertenties
Referenties:
1
"FDA Public Health Notification: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
Bloodborne Pathogens: Initial Communication" (2010) http://www .fda .gov/MedicalDevices/Safety/
AlertsandNotices/ucm224025 .htm
"CDC Clinical Reminder: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
2
Bloodborne Pathogens" (2010) http://www .cdc .gov/injectionsafety/Fingerstick-DevicesBGM .html
3
Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF
consultation . World Health Organization, Geneva, Switzerland 2006 .
Product Inserts: HumaLog®, NovoLog®, Apidra®
4
Diabetes Care . January 2010, vol . 33, no . Supplement 1, S11-S61 .
5
6
Hirsch, I . (2005) . Glycemic Variability: It's Not Just About A1C Anymore! Diabetes Technology and Therapeutics,
7 (5), 780-783 .
Mayo Clinic Proceedings February 2007, vol . 82, no . 2, 229-236 .
7
Pearson J, Bergenstal R . Fine-Tuning Control: Pattern Management Versus Supplementation: View 1: Pattern
8
Management: an Essential Component of Effective Insulin Management . Diabetes Spectr . April 1, 2001;
14(2)75-78 .
Advertenties
Inhoudsopgave
